Androgenetic Alopecia. Androgenic alopecia
Conditions
Interventions
Intervention 1: Intervention group: The intervention group is treated with topical cetirizine and topical minoxidil solution. First, 38 grams of cetirizine powder is prepared from Amin Pharmaceutical
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: All patient with androgenetic alopecia aged 18 to 50 Patient who are willing to participate in trial
Exclusion criteria
Exclusion criteria: Patient with other types of alopecia Any serious systemic disease Patient who have had a history of hair transplantation in the past History of sensitivity to cetirizine and minoxidil Systemic steroid use for more than 14 days in the last 2 monthes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The increase in density and thickness of hair. Timepoint: before the start of treatment and 4 months after the start of treatment. Method of measurement: Trichogram and standard photography in 4 views. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction score, doctor satisfaction score. Timepoint: The beginning of the study and 4 months after the start of the study. Method of measurement: A 7-point questionnaire to check the level of patient and doctor satisfaction. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSomayeh Maleki
Esfahan University of Medical Sciences
Outcome results
None listed